AN OXOVANADIUM(IV)-CONTAINING N2O2 CHELATE COMPLEX; CRYSTAL STRUCTURE DETERMINATION AND DFT

Year 2016, Volume: 3 Issue: 3, 393 - 402, 08.01.2017

Berat İlhan Ceylan

https://doi.org/10.18596/jotcsa.33245

Cited By: 1

Abstract

A stable oxovanadium(IV) complex was obtained by template condensation of 2-hydroxynaphthaldehyde S-methylthiosemicarbazone and salicylaldehyde in the presence of VOSO₄. The structure of  VO(II) centered metal complex was confirmed  by elemental analysis and was characterized by single crystal X-ray diffraction technique and density functional theory (DFT/B3LYP) LANL2DZ compared with experimental data. The complex crystal is in the form of dark green-colored small sticks. The experimental data of the monoclinic crystalline structure which belonging P1 21/n1 space group was compared to those obtained with DFT-B3LYP-LANDL2DZ. It was seen that experimental and theoretical values are in a good agreement. 

Keywords

Oxovanadium(IV) complexes, thiosemicarbazones, template reaction, crystal structure, DFT.

References

• Pahontu E, Julea F, Rosu T, Purcarea V, Chumakov Y, Petrenco P, et al. Antibacterial, antifungal and in vitro antileukaemia activity of metal complexes with thiosemicarbazones. Journal of Cellular and Molecular Medicine. 2015; 19(4): 865–78. DOI: 10.1111/jcmm.12508.
• Da S. Maia PI, Pavan FR, Leite CQF, Lemos SS, de Sousa GF, Batista AA, et al. Vanadium complexes with thiosemicarbazones: Synthesis, characterization, crystal structures and anti-Mycobacterium tuberculosis activity. Polyhedron. 2009; 28(2): 398–406.
• DOI: 10.1016/j.poly.2008.11.017.
• Ülküseven B. Studies of the S-Ethylthiosemicarbazones with Cu(I), Zn(II), Cd(II), Hg(II) Chloride Salts. Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry. 1995; 25(9): 1549–60. DOI: 10.1016/j.poly.2008.11.017.
• Bourosh P, Gerbeleu N, Revenko M, Simonov Y, Belskii V, Byrotosu N. Preparation and crystal structure of salicylaldehyde S-methyl-4-phenylthiosemicarbazone (H2L) and its copper complex [Cu(HL)H2O] NO3. Russ J Inorg Chem. 1987; 32:1446–50.
• Lewis NA, Liu F, Seymour L, Magnusen A, Erves TR, Arca JF, et al. Synthesis, Characterisation, and Preliminary In Vitro Studies of Vanadium(IV) Complexes with a Schiff Base and Thiosemicarbazones as Mixed Ligands. European Journal of Inorganic Chemistry. 2012; 4: 664–77. DOI: 10.1002/ejic.201100898.
• Noblıa P, Vieites M, Torre M.H, Costa-Filho A.J, Cerecetto H, Gonzalez M, Laura Lavaggi M, Adachi Y, Sakurai H, Gambino D. Journal of Inorganic Biochemistry. 2006; 100: 281–87. DOI :10.1016/j.jinorgbio.2005.11.012.
• Sanna D, Ugone V, Pisano L, Serra M, Micera M, Garribba E, Journal of Inorganic Biochemistry. 2015; 153: 167–77. DOI:10.1016/j.jinorgbio.2015.07.018.
• Ying P, Zeng P, Lu J, Chen H, Liao X, Yang N. New Oxidovanadium Complexes Incorporating Thiosemicarbazones and 1, 10-Phenanthroline Derivatives as DNA Cleavage, Potential Anticancer Agents, and Hydroxyl Radical Scavenger. Chemical Biology & Drug Design. 2015; 86(4): 926–37. DOI: 10.1111/cbdd.12535.
• Rubčić M, Milić D, Horvat G, Đilović I, Galić N, Tomišić V, et al. Vanadium-induced formation of thiadiazole and thiazoline compounds. Mononuclear and dinuclear oxovanadium(v) complexes with open-chain and cyclized thiosemicarbazone ligands. Dalton Transactions. 2009; 44: 9914. DOI: 10.1039/b913653c.
• Springer SD, Butler A. Microbial ligand coordination: Consideration of biological significance. Coordination Chemistry Reviews. 2016; 306: 628–35.
• DOI: 10.1016/j.ccr.2015.03.013.
• Ilhan-Ceylan B, Tuzun E, Kurt Y, Acikgoz M, Kahraman S, Atun G, et al. Oxovanadium(IV) complexes based on S -alkyl-thiosemicarbazidato ligands. Synthesis, characterization, electrochemical, and antioxidant studies. Journal of Sulfur Chemistry. 2015; 36(4): 434–49. DOI: 10.1080/17415993.2015.1050396.
• Yanardag R, Demirci TB, Ülküseven B, Bolkent S, Tunali S, Bolkent S. Synthesis, characterization and antidiabetic properties of N1-2,4-dihydroxybenzylidene-N4-2-hydroxybenzylidene-S-methyl-thiosemicarbazidato-oxovanadium(IV).European Journal of Medicinal Chemistry. 2009; 44(2): 818–26. DOI: 10.1016/j.ejmech.2008.04.023.
• Sheldrick G. SHELXS-97, Program for Crystal Structure Solution, Univ. Göttingen, Germany. 1997
• Sheldrick G. SHELXL2014/1 Programs for the Solution and Refinement of Crystal Structures. University of Göttingen; 2014.
• Sheldrick GM. A short history of SHELX. Acta Crystallographica Section A Foundations of Crystallography. 2008; 64(1): 112–22.
• M.J. Frisch, G.W. Trucks, H.B. Schlegel, G. Scuseria, M. Robb, J. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. Petersson. Gaussian 09, Revision A. 02, Gaussian, Inc., Wallingford, CT, 2009; 200.
• Frisch M, Trucks G, Schlegel HB, Scuseria G, Robb M, Cheeseman J, et al. Gaussian 09, Revision A. 02, Gaussian. Inc, Wallingford, CT. 2009; 200.